Source link : https://newshealth.biz/health-news/linvoseltamab-approved-for-r-r-multiple-myeloma/
The FDA has granted accelerated approval to linvoseltamab (Lynozyfic, Regeneron) for relapsed or refractory multiple myeloma (MM) after at least four prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti‑CD38 monoclonal antibody. The bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager joins two others already on the US market for […]
The post Linvoseltamab Approved for R/R Multiple Myeloma first appeared on News Health.
—-
Author : News Health
Publish date : 2025-07-02 21:11:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8